Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit Disorder with Hyperactivity

Explore clinical trials studying Attention Deficit Disorder with Hyperactivity. Study availability and eligibility vary by location and protocol.

1,408 public trials 160 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit Disorder with Hyperactivity trial results

Completed

Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17

NCT00763971

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • ZiekenhuisNetwerk Antwerpen, Commandant Weynsstraat 165, Campus Hoge Beuken Hoboken, Antwerp, Belgium
  • Universitair Ziekenhuis Gent, Kinder-en Jeugdpsychiatrie, De Pintelaan 185 Ghent, East Flanders, Belgium
  • Afdeling Psychiatrie, UZ Herestraat 49, Bus 07003 Leuven, Belgium
  • Hospital Archet 2 Nice, Cedex 03, France
View all 49 locations
View Trial Details
Completed

Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study

NCT00764868

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Valley Clinical Research, Inc. El Centro, California, United States
  • Penninsula Research Associates, Inc. Rolling Hills Estates, California, United States
  • Psychiatric Centers at San Diego (PCSD-Feighner Research Institute) San Diego, California, United States
View all 45 locations
View Trial Details
Completed

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

NCT01106430

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Harmonex Neuroscience Research, Inc Dothan, Alabama, United States
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Shanti Clinical Trials Colton, California, United States
  • Psychiatric Centers at San Diego Feighner Research San Diego, California, United States
View all 64 locations
View Trial Details
Completed

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

NCT01552902

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Harmonex Neuroscience Research, Inc. Dothan, Alabama, United States
  • Center for Advanced Improvement Tucson, Arizona, United States
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Shanti Clinical Trials Colton, California, United States
View all 95 locations
View Trial Details
Completed

Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT01328756

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • ZNA Antwerpen, Commandant Weynsstraat 165 Campus Hoge Beuken Hoboken, Antwerp, Belgium
  • Afdeling Psychiatrie Leuven, Belgium
  • Albert-Ludwigs-Universität Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Zentralinstitut für Seelische Gesundheit Mannheim Mannheim, Baden-Wurttemberg, Germany
View all 35 locations
View Trial Details
Completed

Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

NCT00697515

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • University of CA, Irvine Child Development Center Irvine, California, United States
  • Vince & Associates Clinical Research Overland Park, Kansas, United States
  • Center for Psychiatry & Behavioral Medicine, Inc Las Vegas, Nevada, United States
View Trial Details

Related conditions